What this study is
The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of hemorrhoid artery embolization (HAE) for symptomatic bleeding internal hemorrhoids in adults aged 18 years or older that have not responded to medical therapy.
The main question it aims to answer are:
1) Does HAE lead to sustained improvement in bleeding (HDSS scores over 12-36 months?
Participants will:
- Undergo HAE as part of their routine clinical care.
- Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires.
- Have safety outcomes tracked according to Society of Interventional Radiology guidelines.
There is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.
What's being tested
- Hemorrhoid Artery Embolization
Intervention · PROCEDURE
Hemorrhoidal Artery Embolization (HAE)-often referred to clinically as the Emborrhoid technique-is a minimally invasive, image-guided procedure in which embolic agents are delivered into the superior rectal arteries to reduce hypervascular blood flow, thereby shrinking engorged hemorrhoidal plexuses and alleviating chronic bleeding and discomfort from internal hemorrhoids.
Study details
- Official title
- Creation Of a Prospective Registry For Hemorrhoid Artery Embolization At The Joint & Vascular Institute
- Sponsor
- Joint & Vascular Institute
- Conditions
- Hemorrhoid · Internal Hemorrhoids · Hemorrhoid Bleeding · Hemorrhoidal Bleeding · Internal Hemorrhoid
- Enrolling
- 1,200 people
- Starts
- 2026-01-18
- Est. completion
- 2032-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Adults (≥18 years) with symptomatic bleeding internal hemorrhoids refractory to medical therapy, referred for HAE.
You can't join if
- Pregnancy, coagulopathy, severe comorbidities, or inability to consent.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openJoint and Vascular Institute
Libertyville, Illinois, United States
- Layth Alkhani, BS · Contact847-584-3959lalkhani@jointvascular.com
Recruiting
Study team
Sponsor
Joint & Vascular Institute
Study ID 1395380
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.